Error: Could not add to watchlist. X

CSL Ltd

+ Watchlist
CMXHY:US
Ticker Delisted
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
951.671
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.
ADDRESS
45 Poplar Road
Parkville, VIC 3052
Australia
PHONE
61-3-9389-1911
  • John Shine
    Chairman
  • Paul Perreault
    CEO/Managing Director
  • Gordon Naylor
    Chief Financial Officer
  • Mary Sontrop
    Exec VP:Manufacturing
  • Gregory Boss "Greg"
    Exec VP:Legal/Gen Cnsl
Show More